Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - azd1222 -

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - acalabrutinib -

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - benralizumab -

Irska - engleski - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - rosuvastatin - tablets - 10mg milligram

Irska - engleski - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - rosuvastatin - tablets - 20mg milligram

Irska - engleski - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - rosuvastatin - tablets - 40mg milligram

Australija - engleski - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - hydrochlorothiazide; candesartan cilexetil -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - ticagrelor -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - indications ast at 24 june 2004: for relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm. bricanyl injection: bricanyl injection solution is recommended for acute use only.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1.8 mg/ml;   - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection